Management of the patient with ST elevation myocardial infarction requires inhibition of both the generation of thrombin (i.e inhibition of the coagulation cascade via antithrombins) as well as the platelet (via antiplatelet agents).  Selection of the appropriate antithrombin depends upon a variety of factors including the choice of revascularization strategy. This chapter reviews data supporting the optimal selection of both parenteral<unk>  and oral<unk> <unk>  agents for a given patient.
ST elevation myocardial infarction anticoagulant and antithrombotic therapy
Unstable angina / non ST elevation myocardial infarction anticoagulant therapy
ST elevation myocardial infarction fibrinolytic therapy
ST elevation myocardial infarction aspirin therapy
ST elevation myocardial infarction initial care
ST elevation myocardial infarction calcium channel blocker therapy
ST elevation myocardial infarction reperfusion therapy
Unstable angina / non ST elevation myocardial infarction low molecular weight heparin therapy